Exciting Alzheimer's Research Presented in Chicago

Since Congress passed the National Alzheimer's Project Act (NAPA), Alzheimer's and dementia research funding at the National Institutes of Health (NIH) has quadrupled. These increases have enabled...

Read More

Bold Action on Alzheimer's

Across the country, state and local public health departments are taking action to fight to end Alzheimer's. One trusted resource they use is The Healthy Brain Initiative: The Public Health Road Map...

Read More

NIH launches of All of Us Research Program

The National Institutes of Health (NIH) has recently launched All of Us, a large research program. Part of the Precision Medicine Initiative the mission of All of Us is to speed up health research and...

Read More

BOLD Infrastructure for Alzheimer's Act Reaches Critical Mass in U.S. Senate and House of Representatives

In recent months we've seen our share of successes in Congress. In March, both chambers passed a fiscal year 2018 spending bill which included a landmark $414 million in additional funding for...

Read More

Taking the Case to Congress

Today, I had the pleasure to testify before the House Committee on Appropriations Subcommittee on Labor, Health and Human Services (HHS), Education and Related Agencies about the need to further...

Read More

Is 2018 the Tipping Point in the Fight Against Alzheimer's?

The 2018 midterms may be the most important election in the next decade. The entire U.S. House of Representatives, one third of the U.S. Senate and 36 gubernatorial seats are up in November. Democrats...

Read More

Dementia Caregiving in the United States

In 2017, 16.1 million Americans provided unpaid care for people with Alzheimer's or other dementias. These caregivers provide an estimated 18.4 billion hours of care valued at over $232 billion...

Read More

New Biological Research Framework for Alzheimer's Released

The Alzheimer's Association and the National Institute on Aging (NIA) have published a new Research Framework that proposes shifting the definition of Alzheimer's disease for research use only. The...

Read More

FDA Issues Draft Guidance on Alzheimer's drug development

Yesterday, the Food and Drug Administration (FDA) released a new guidance document for how researchers can best approach drug development for early Alzheimer's disease. Specifically, the FDA is...

Read More

Dementia Care Practice Recommendations Presented on Capitol Hill

Yesterday, the Alzheimer's Association hosted a briefing on Capitol Hill to highlight the Association's 2018 Dementia Care Practice Recommendations. The recommendations are aimed at helping nursing...

Read More